SEC Form 4Coverage since Aug 3, 2026
$GRTX insider trading
Over the last 12 months, Galera Therapeutics insiders reported no purchases and 5 sales totaling — across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- — 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $GRTX · 12Mvia TradingView
Top insiders · 12m
Alleva Lawrence M—2× · —
FRIEDMAN MICHAEL R.—1× · —
Sorensen MelPresident and CEO1× · —
CHANG NANCY T—1× · —
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | FRIEDMAN MICHAEL R.D | ▽ Sale to issuer | 41,631 | — | — | -100% | indirect |
| Aug 3, 2026 | Sorensen MelPresident and CEO · O·D | ▽ Sale to issuer | 975 | — | — | -100% | — |
| Aug 3, 2026 | Alleva Lawrence MD | ▽ Sale to issuer | 40 | — | — | -100% | indirect |
| Aug 3, 2026 | Alleva Lawrence MD | ▽ Sale to issuer | 11 | — | — | -100% | — |
| Aug 3, 2026 | CHANG NANCY TD·10% | ▽ Sale to issuer | 47,434 | — | — | -100% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GRTX feed.